Over the past few decades, transcatheter aortic valve replacement (TAVR) has emerged as a less invasive alternative to surgical aortic valve replacement [1][2][3]. Although there was a tremendous survival advantage and symptom benefit for many patients undergoing TAVR, compared with medical therapy, some patients died soon after the procedures [4,5]. Recently, variable frailty markers have been developed to guide better patient selection and are considered to be essential components of patient care in TAVR [6][7][8][9].The revised Hasegawa's dementia scale (HDS-R), which is composed of nine simple questions, was initially developed in